Literature DB >> 3788968

The effect of dosing strategy on kidney cortical accumulation of aminoglycosides in rats.

R A Giuliano, G A Verpooten, M E De Broe.   

Abstract

The influence of three different dosage schedules on kidney cortical accumulation of aminoglycosides was studied in rats. A daily dose of 10 mg/kg of gentamicin or tobramycin or 33.3 mg/kg of amikacin were given, either in single injections, three injections eight hours apart, or by continuous infusion. Kidney cortical levels of aminoglycosides were examined at regular intervals up to eight days. The pattern for cortical accumulation under different dose regimens was drug-dependent. Continuous infusion of gentamicin resulted in remarkably higher cortical concentrations than after intermittent administrations. In contrast, cortical levels of tobramycin were independent of the regimen used. For amikacin, higher accumulation resulted from continuous administration from the second day. However, the differences in tissue levels after one or the other dose regimen were less striking than for gentamicin. These observations were explained by differences in cortical uptake kinetics for aminoglycosides previously reported. Elevations in serum concentrations of gentamicin were associated with nonlinear uptake. Accordingly, uptake of gentamicin is more "efficient" at low serum concentrations. Uptake of tobramycin was linearly related to increases in serum levels. Amikacin showed a mixed kinetics pattern, saturation at low serum levels, and linear kinetics at high serum concentrations. This explains the higher cortical levels reached with continuous infusion of amikacin compared with intermittent administration. Uptake kinetics play an essential role in cortical aminoglycoside concentrations achieved after different dosing strategies. The design of regimens minimizing cortical uptake may decrease the risk of nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3788968     DOI: 10.1016/s0272-6386(86)80101-9

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

Review 1.  Antibacterial-induced nephrotoxicity in the newborn.

Authors:  V Fanos; L Cataldi
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

Review 2.  Once-daily aminoglycoside therapy.

Authors:  D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  Effect of isepamicin dosing scheme on concentration in cochlear tissue.

Authors:  P J Govaerts; J Claes; P H Van de Heyning; M P Derde; L Kaufman; J F Marquet; M E De Broe
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 4.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  A concept for pharmacokinetic-pharmacodynamic dosage adjustment in renal impairment: the case of aminoglycosides.

Authors:  D Czock; M Giehl; F Keller
Journal:  Clin Pharmacokinet       Date:  2000-04       Impact factor: 6.447

6.  Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections.

Authors:  P J de Vries; R P Verkooyen; P Leguit; H A Verbrugh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

7.  Risk factors for toxicity in elderly patients given aminoglycosides once daily.

Authors:  D L Paterson; J M Robson; M M Wagener
Journal:  J Gen Intern Med       Date:  1998-11       Impact factor: 5.128

8.  Gentamicin dosing strategies for dogs with subclinical renal dysfunction.

Authors:  D L Frazier; J E Riviere
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

Review 9.  What is the evidence for once-daily aminoglycoside therapy?

Authors:  M L Barclay; E J Begg; K G Hickling
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447

10.  Systemic tobramycin concentrations during selective decontamination of the digestive tract in intensive care unit patients on continuous venovenous hemofiltration.

Authors:  Meriel Mol; Hendrikus J M van Kan; Marcus J Schultz; Evert de Jonge
Journal:  Intensive Care Med       Date:  2008-02-19       Impact factor: 17.440

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.